Cat. No S57CPTD784481_50_MG
US-CATO

Product Information

Product Name
Abaloparatide Acetate
Brand Name
US-CATO
Product Number
CPTD784481
CAS
247062-33-5
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
76943386
IUPAC Name
(4S)-4-(2S)-2-(2S)-2-(2S)-2-(2S)-2-(2S)-2-(2S)-5-amino-2-(2S,3S)-2-(2S)-2-(2S)-6-amino-2-2-(2S)-6-amino-2-(2S)-2-(2S)-2-(2S)-2-(2S)-2-(2S)-5-amino-2-(2S)-2-(2S)-2-(2S)-2-(2S)-2-(2S)-2-aminopropanoylamino-3-methylbutanoylamino-3-hydroxypropanoylamino-4-carboxybutanoylamino-3-(1H-imidazol-5-yl)propanoylamino-5-oxopentanoylamino-4-methylpentanoylamino-4-methylpentanoylamino-3-(1H-imidazol-5-yl)propanoylamino-3-carboxypropanoylaminohexanoylaminoacetylaminohexanoylamino-3-hydroxypropanoylamino-3-methylpentanoylamino-5-oxopentanoylamino-3-carboxypropanoylamino-4-methylpentanoylamino-5-carbamimidamidopentanoylamino-5-carbamimidamidopentanoylamino-5-carbamimidamidopentanoylamino-5-(2S)-1-(2S)-1-(2S)-1-(2S)-6-amino-1-(2S)-1-(2S)-1-1-(2S)-6-amino-1-(2S)-1-(2S)-1-(2S,3R)-1-(2S)-1-amino-1-oxopropan-2-ylamino-3-hydroxy-1-oxobutan-2-ylamino-3-(1H-imidazol-5-yl)-1-oxopropan-2-ylamino-4-methyl-1-oxopentan-2-ylamino-1-oxohexan-2-ylamino-2-methyl-1-oxopropan-2-ylamino-4-methyl-1-oxopentan-2-ylamino-4-methyl-1-oxopentan-2-ylamino-1-oxohexan-2-ylamino-4-carboxy-1-oxobutan-2-ylamino-4-methyl-1-oxopentan-2-ylamino-4-methyl-1-oxopentan-2-ylamino-5-oxopentanoic acid
InChI Key
BVISQZFBLRSESR-XSCWXTNMSA-N
SMILES
CCC@H(C)C@@H(C(=O)NC@@H(CCC(=O)N)C(=O)NC@@H(CC(=O)O)C(=O)NC@@H(CC(C)C)C(=O)NC@@H(CCCNC(=N)N)C(=O)NC@@H(CCCNC(=N)N)C(=O)NC@@H(CCCNC(=N)N)C(=O)NC@@H(CCC(=O)O)C(=O)NC@@H(CC(C)C)C(=O)NC@@H(CC(C)C)C(=O)NC@@H(CCC(=O)O)C(=O)NC@@H(CCCCN)C(=O)NC@@H(CC(C)C)C(=O)NC@@H(CC(C)C)C(=O)NC(C)(C)C(=O)NC@@H(CCCCN)C(=O)NC@@H(CC(C)C)C(=O)NC@@H(CC1=CN=CN1)C(=O)NC@@H(C@@H(C)O)C(=O)NC@@H(C)C(=O)N)NC(=O)C@H(CO)NC(=O)C@H(CCCCN)NC(=O)CNC(=O)C@H(CCCCN)NC(=O)C@H(CC(=O)O)NC(=O)C@H(CC2=CN=CN2)NC(=O)C@H(CC(C)C)NC(=O)C@H(CC(C)C)NC(=O)C@H(CCC(=O)N)NC(=O)C@H(CC3=CN=CN3)NC(=O)C@H(CCC(=O)O)NC(=O)C@H(CO)NC(=O)C@H(C(C)C)NC(=O)C@H(C)N

References

Optimizing Bone Health in Diabetes: Strategies for Fracture Risk Reduction in Public Healthcare

Publication Name: Current Diabetes Reports
Publication Date: 2025-07-21
DOI: 10.1007/s11892-025-01599-x

Probability of achieving treatments goals with twice-weekly teriparatide followed by bisphosphonate in Japanese postmenopausal osteoporosis

Publication Name: Journal of Bone and Mineral Metabolism
Publication Date: 2025-07-15
DOI: 10.1007/s00774-025-01626-7

Effect of FRAXplus adjustments on fracture risk reclassification in older Swedish women—results from the SUPERB-study

Publication Name: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Publication Date: 2025-07-11
DOI: 10.1007/s00198-025-07588-w

Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis

Publication Name: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Publication Date: 2025-07-11
DOI: 10.1007/s00198-025-07602-1

Abaloparatide Acetate

Just added to your wishlist:
My Wishlist
You've just added this product to the cart:
Go to cart page